tobramycin has been researched along with Ventilator-Associated Pneumonia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| Dumas, JL; Köhler, T; Reinhardt, A; Ricou, B; Rohner, P; van Delden, C; Wood, P | 1 |
| Abbasi, S; Ataei, B; Hakamifard, A; Homayouni, A; Khorvash, F; Torfeh Esfahani, AA | 1 |
| Dhand, R | 1 |
| Akbari, N; Angermair, S; Asgarpur, G; Deja, M; Grehn, C; Schwarz, C; Spies, C; Thronicke, A; Treskatsch, S; Uhrig, A | 1 |
| Ataei, B; Farsaei, S; Gudarzi, M; Hakamifard, A; Khorvash, F; Mohajeri, F; Yaghoubi, S | 1 |
| Gommers, D; Hoek, R; Karami, M; Stokker, J; van der Eerden, M | 1 |
| Hirosako, S; Kamohara, H; Kinoshita, Y; Kohrogi, H; Migiyama, E; Migiyama, Y; Sagishima, K; Tashiro, T; Tokunaga, K | 1 |
| Confreda, K; LaPlante, K; Shurko, J; Tarquinio, K | 1 |
| Farrell, DJ; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Eagye, KJ; Kuti, JL; Nicasio, AM; Nicolau, DP; Palter, M; Pepe, J; Shore, E | 1 |
| Boucher, BA; Croce, MA; Czosnowski, QA; Fabian, TC; Magnotti, LJ; Swanson, JM; Wood, GC | 1 |
| Cox, JC; Drachman, DA; Hibbard, ML; Kopelman, TR; Maly, TJ; Matthews, MR; O'Neill, PJ; Quan, AN; Vail, SJ | 1 |
| Arnold, HM; Kollef, MH; Sawyer, AM | 1 |
| Moore, ME; Mueller, EW | 1 |
| Cooper, A; Joshi, M; Kassira, W; McCarthy, M; Metzler, M; Olvey, S | 1 |
| Baracco, G; Cohn, SM; Crookes, B; Habib, F; Hallal, A; Manning, RJ; Namias, N; Schulman, CI | 1 |
| Allaouchiche, B; Boselli, E; Breilh, D; Djabarouti, S; Gordien, JB; Guillaume, C; Rimmelé, T; Saux, MC; Xuereb, F | 1 |
| Dahyot-Fizelier, C; Mimoz, O | 1 |
| Bulut, T; Dongelmans, DA; Korevaar, JC; Schultz, MJ; Spronk, PE; Veelo, DP | 1 |
7 trial(s) available for tobramycin and Ventilator-Associated Pneumonia
| Article | Year |
|---|---|
Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: An open-label randomized controlled trial.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Fosfomycin; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Tobramycin; Treatment Outcome | 2023 |
A prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled Tobramycin in patients with ventilator-associated pneumonia (iToVAP).
Topics: Administration, Inhalation; Anti-Bacterial Agents; Humans; Pneumonia, Ventilator-Associated; Prospective Studies; Tobramycin; Treatment Outcome | 2023 |
Comparison of two therapeutic approaches for the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter: a randomized clinical trial study.
Topics: Acinetobacter; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Tobramycin | 2020 |
Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trial.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Double-Blind Method; Humans; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2020 |
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Protease Inhibitors; Tazobactam; Tobramycin; Treatment Outcome | 2006 |
Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study.
Topics: Acinetobacter; Acinetobacter Infections; Administration, Inhalation; Adult; Aged; Anti-Bacterial Agents; APACHE; Creatinine; Double-Blind Method; Female; Hospitals, University; Humans; Injections, Intravenous; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2007 |
Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchoalveolar Lavage; Chromatography, High Pressure Liquid; Critical Illness; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Reproducibility of Results; Respiratory Mucosa; Tobramycin | 2007 |
12 other study(ies) available for tobramycin and Ventilator-Associated Pneumonia
| Article | Year |
|---|---|
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Longitudinal Studies; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Inhaled Tobramycin for Treatment of Ventilator-Associated Pneumonia: The Interplay of Patient, Drug, and Device.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Humans; Patients; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Tobramycin | 2022 |
Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndrome.
Topics: Administration, Inhalation; Aerosols; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Female; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Distress Syndrome; Retrospective Studies; Tobramycin; Treatment Outcome | 2017 |
Activities of tobramycin and polymyxin E against Pseudomonas aeruginosa biofilm-coated medical grade endotracheal tubes.
Topics: Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Humans; Intubation, Intratracheal; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2014 |
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Enterobacter; Humans; Klebsiella; Microbial Sensitivity Tests; Pneumonia; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2015 |
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Pathways; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Observation; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Adult; Aerosols; Amikacin; Anti-Bacterial Agents; APACHE; Colistin; Critical Illness; Drug Resistance, Multiple; Female; Glasgow Coma Scale; Gram-Negative Bacteria; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Tobramycin; Treatment Outcome | 2009 |
Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tobramycin | 2010 |
Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Inhalation; Aerosols; Anti-Bacterial Agents; APACHE; Bronchoalveolar Lavage; Colistin; Comorbidity; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Statistics, Nonparametric; Survival Rate; Tobramycin; Treatment Outcome | 2012 |
Aerosolized antibiotic therapy: a forward aerial assault or forced contingency for ventilator-associated pneumonia?
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Tobramycin | 2012 |
Mini-broncho-alveolar lavage: a simple and promising method for assessment of antibiotic concentration in epithelial lining fluid.
Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage; Chromatography, High Pressure Liquid; Critical Illness; Humans; Infusions, Intravenous; Intensive Care Units; Pneumonia, Ventilator-Associated; Respiratory Mucosa; Tobramycin | 2007 |
The incidence and microbial spectrum of ventilator-associated pneumonia after tracheotomy in a selective decontamination of the digestive tract-setting.
Topics: Administration, Buccal; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Colistin; Critical Illness; Cross Infection; Decontamination; Enteral Nutrition; Female; Gastrointestinal Tract; Humans; Incidence; Intensive Care Units; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Netherlands; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Staphylococcus aureus; Tobramycin; Tracheotomy | 2008 |